News

690 coinfected Canadians without significant fibrosis or end stage liver disease were included in a study of the progression of liver disease and marijuana. 53% of the participants had ...

It has been shown that the HBV-DNA level in HBeAg negative chronic hepatitis B infection predicts the risk of hepatocellular cancer (HCC) if HBV-DNA is greater than 2,000 IU/ml. ...

Forty-four patients on suppressive HIV therapy for at least 96 weeks with CD4 counts <350 were randomized 2:1 to adding raltegravir to the ongoing therapy or to continue the ongoing ...

176 Spanish patients with chronic hepatitis B that initiated tenofovir therapy were followed for 96 weeks. A majority were coinfected with HIV.

In an ongoing study of tenofovir/emtricitabine versus tenofovir/placebo in patients with high baseline HBV DNA and normal ALT the study has reached 192 weeks. Tenfovir/emtricitabin ...

Hepatocellular cancer (HCC) risk was evaluated in a community based study cohort (REVEAL-HBV community based study cohort). Patients with detectable HBV DNA were analyzed ...

Hepatitis E is usually considered to be a self limiting infection with a benign prognosis. Two cases of chronic hepatitis E were recently reported from Spain in HIV infected men with ...

In a recent CDC report it is estimated that 2.7–3.9 million people in the US are living with HCV-infection. Most persons are unaware of their infection. Surveillance data from 2005–2011...

In the EUROSIDA cohort patients with coinfection with hepatitis C and HIV were studied to evaluate the influence of hepatitis C viremia and genotype on mortality. Of a total of more ...

14 patients who received ART during primary infection and who had long-term viral control after treatment interruption were identified in the French Visconti study. The median treatment...

Pages